Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study
PaperCitations, authors & open-access status
Pembrolizumab Plus Chemotherapy in Squamous Non–Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 537 citations, 2023 year and hybrid oa status.
537
Citations
2023
Year
hybrid
OA Status